Radio-immunoassay_detection_of_interferon-gamma_in_urine_after_intravesical_Evans_BCG_therapy__Our_previous_studies_suggested_that_interferon-gamma_(IFN_gamma)_was_produced_in_the_local_immune_response_to_intravesical_BCG._To_confirm_this_we_modified_a_commercially_available_radio-immunoassay_for_detection_of_this_lymphokine_in_urine._The_urinary_levels_of_IFN_gamma_were_compared_in_serial_urine_samples_taken_from_six_patients_undergoing_treatment_with_Evans_strain_BCG_and_seven_patients_receiving_intravesical_mitomycin_C/epirubicin._IFN_gamma_was_detected_consistently_in_response_to_BCG_with_levels_reaching_a_peak_(mean_67.1_U/ml.,_range_7.9_to_155.9_U/ml.)_four_to_six_hours_post-instillation_whereas_after_other_intravesical_agents_no_IFN_gamma_was_detectable_after_seven_of_13_instillations._After_the_remaining_six_instillations_lower_levels_were_detected_(mean_7.4_U/ml.,_range_0.6_to_22.4_U/ml.)._The_difference_in_peak_levels_between_the_two_groups_was_statistically_significant_(p_less_than_0.001_Mann_Whitney_U_test)._These_results_are_further_evidence_of_specific_cellular_immune_activity_in_response_to_intravesical_BCG_therapy_and_suggest_anti-tumour_mechanisms_similar_to_allograft_rejection_and_autoimmunity.